Google can render JavaScript. That’s no longer up for debate. But that doesn’t mean it always does — or that it does so instantly or perfectly. Since Google’s 2024 comments suggesting it renders all ...

Atom Power, a technology company focused on electric vehicle charging infrastructure, has added the E100 Series to its Atom EV Level 2 EV charging solutions. The E100 Series is designed to charge ...

Potensic’s Atom 2 is an affordable, portable drone that doesn’t require FAA registration. I appreciated how it balances that small size with capable controls and video and photography chops. The body ...

Scientists have taken a major step toward mimicking nature’s tiniest gateways by creating ultra-small pores that rival the dimensions of biological ion channels—just a few atoms wide. The breakthrough ...

Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into executing malicious JavaScript in their browser, allowing attackers to ...

For this week’s Ask An SEO, a reader asked: “Is there any difference between how AI systems handle JavaScript-rendered or interactively hidden content compared to traditional Google indexing? What ...

Cosmos Labs wants to redesign ATOM after its existing model failed to capture value from widespread use of its open-source software. The effort marks a pivot away from its Interchain Security model, ...

The modern Run prompt looks like more of a launcher in the latest preview builds of Windows 11. The modern Run prompt looks like more of a launcher in the latest preview builds of Windows 11. is a ...

Thirty years ago today, Netscape Communications and Sun Microsystems issued a joint press release announcing JavaScript, an object scripting language designed for creating interactive web applications ...

A critical vulnerability in the popular expr-eval JavaScript library, with over 800,000 weekly downloads on NPM, can be exploited to execute code remotely through maliciously crafted input. The ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...